Abstract
IntroductionPancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis with an overall 5-year survival of approximately 8%. The success in reducing the mortality rate of PDAC is related to the discovery...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have